PD-1/PD-L1 inhibitors

Abstract Compounds of Formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GRAUPE, Michael, PARKHILL, Eric Q, WANG, Peiyuan, WATKINS, William J, NADUTHAMBI, Devan, METOBO, Samuel E, CHO, Aesop, MUKHERJEE, Prasenjit Kumar, DU, Zhimin, ZIEBENHAUS, Christopher Allen, MEDLEY, Jonathan William, AKTOUDIANAKIS, Evangelos, LAD, Lateshkumar Thakorlal, XU, Jie, MACHICAO TELLO, Paulo A, PHILLIPS, Barton W, SQUIRES, Neil H, YANG, Kin Shing, SIMONOVICH, Scott Preston
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GRAUPE, Michael
PARKHILL, Eric Q
WANG, Peiyuan
WATKINS, William J
NADUTHAMBI, Devan
METOBO, Samuel E
CHO, Aesop
MUKHERJEE, Prasenjit Kumar
DU, Zhimin
ZIEBENHAUS, Christopher Allen
MEDLEY, Jonathan William
AKTOUDIANAKIS, Evangelos
LAD, Lateshkumar Thakorlal
XU, Jie
MACHICAO TELLO, Paulo A
PHILLIPS, Barton W
SQUIRES, Neil H
YANG, Kin Shing
SIMONOVICH, Scott Preston
description Abstract Compounds of Formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2021204222BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2021204222BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2021204222BB23</originalsourceid><addsrcrecordid>eNrjZBANcNE11AcSPoYKmXkZmUmZJflFxTwMrGmJOcWpvFCam0HFzTXE2UM3tSA_PrW4IDE5NS-1JN4x1MjAyNDIwMTIyMjJyciYSGUAmmEg8g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PD-1/PD-L1 inhibitors</title><source>esp@cenet</source><creator>GRAUPE, Michael ; PARKHILL, Eric Q ; WANG, Peiyuan ; WATKINS, William J ; NADUTHAMBI, Devan ; METOBO, Samuel E ; CHO, Aesop ; MUKHERJEE, Prasenjit Kumar ; DU, Zhimin ; ZIEBENHAUS, Christopher Allen ; MEDLEY, Jonathan William ; AKTOUDIANAKIS, Evangelos ; LAD, Lateshkumar Thakorlal ; XU, Jie ; MACHICAO TELLO, Paulo A ; PHILLIPS, Barton W ; SQUIRES, Neil H ; YANG, Kin Shing ; SIMONOVICH, Scott Preston</creator><creatorcontrib>GRAUPE, Michael ; PARKHILL, Eric Q ; WANG, Peiyuan ; WATKINS, William J ; NADUTHAMBI, Devan ; METOBO, Samuel E ; CHO, Aesop ; MUKHERJEE, Prasenjit Kumar ; DU, Zhimin ; ZIEBENHAUS, Christopher Allen ; MEDLEY, Jonathan William ; AKTOUDIANAKIS, Evangelos ; LAD, Lateshkumar Thakorlal ; XU, Jie ; MACHICAO TELLO, Paulo A ; PHILLIPS, Barton W ; SQUIRES, Neil H ; YANG, Kin Shing ; SIMONOVICH, Scott Preston</creatorcontrib><description>Abstract Compounds of Formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230216&amp;DB=EPODOC&amp;CC=AU&amp;NR=2021204222B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230216&amp;DB=EPODOC&amp;CC=AU&amp;NR=2021204222B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GRAUPE, Michael</creatorcontrib><creatorcontrib>PARKHILL, Eric Q</creatorcontrib><creatorcontrib>WANG, Peiyuan</creatorcontrib><creatorcontrib>WATKINS, William J</creatorcontrib><creatorcontrib>NADUTHAMBI, Devan</creatorcontrib><creatorcontrib>METOBO, Samuel E</creatorcontrib><creatorcontrib>CHO, Aesop</creatorcontrib><creatorcontrib>MUKHERJEE, Prasenjit Kumar</creatorcontrib><creatorcontrib>DU, Zhimin</creatorcontrib><creatorcontrib>ZIEBENHAUS, Christopher Allen</creatorcontrib><creatorcontrib>MEDLEY, Jonathan William</creatorcontrib><creatorcontrib>AKTOUDIANAKIS, Evangelos</creatorcontrib><creatorcontrib>LAD, Lateshkumar Thakorlal</creatorcontrib><creatorcontrib>XU, Jie</creatorcontrib><creatorcontrib>MACHICAO TELLO, Paulo A</creatorcontrib><creatorcontrib>PHILLIPS, Barton W</creatorcontrib><creatorcontrib>SQUIRES, Neil H</creatorcontrib><creatorcontrib>YANG, Kin Shing</creatorcontrib><creatorcontrib>SIMONOVICH, Scott Preston</creatorcontrib><title>PD-1/PD-L1 inhibitors</title><description>Abstract Compounds of Formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBANcNE11AcSPoYKmXkZmUmZJflFxTwMrGmJOcWpvFCam0HFzTXE2UM3tSA_PrW4IDE5NS-1JN4x1MjAyNDIwMTIyMjJyciYSGUAmmEg8g</recordid><startdate>20230216</startdate><enddate>20230216</enddate><creator>GRAUPE, Michael</creator><creator>PARKHILL, Eric Q</creator><creator>WANG, Peiyuan</creator><creator>WATKINS, William J</creator><creator>NADUTHAMBI, Devan</creator><creator>METOBO, Samuel E</creator><creator>CHO, Aesop</creator><creator>MUKHERJEE, Prasenjit Kumar</creator><creator>DU, Zhimin</creator><creator>ZIEBENHAUS, Christopher Allen</creator><creator>MEDLEY, Jonathan William</creator><creator>AKTOUDIANAKIS, Evangelos</creator><creator>LAD, Lateshkumar Thakorlal</creator><creator>XU, Jie</creator><creator>MACHICAO TELLO, Paulo A</creator><creator>PHILLIPS, Barton W</creator><creator>SQUIRES, Neil H</creator><creator>YANG, Kin Shing</creator><creator>SIMONOVICH, Scott Preston</creator><scope>EVB</scope></search><sort><creationdate>20230216</creationdate><title>PD-1/PD-L1 inhibitors</title><author>GRAUPE, Michael ; PARKHILL, Eric Q ; WANG, Peiyuan ; WATKINS, William J ; NADUTHAMBI, Devan ; METOBO, Samuel E ; CHO, Aesop ; MUKHERJEE, Prasenjit Kumar ; DU, Zhimin ; ZIEBENHAUS, Christopher Allen ; MEDLEY, Jonathan William ; AKTOUDIANAKIS, Evangelos ; LAD, Lateshkumar Thakorlal ; XU, Jie ; MACHICAO TELLO, Paulo A ; PHILLIPS, Barton W ; SQUIRES, Neil H ; YANG, Kin Shing ; SIMONOVICH, Scott Preston</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2021204222BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GRAUPE, Michael</creatorcontrib><creatorcontrib>PARKHILL, Eric Q</creatorcontrib><creatorcontrib>WANG, Peiyuan</creatorcontrib><creatorcontrib>WATKINS, William J</creatorcontrib><creatorcontrib>NADUTHAMBI, Devan</creatorcontrib><creatorcontrib>METOBO, Samuel E</creatorcontrib><creatorcontrib>CHO, Aesop</creatorcontrib><creatorcontrib>MUKHERJEE, Prasenjit Kumar</creatorcontrib><creatorcontrib>DU, Zhimin</creatorcontrib><creatorcontrib>ZIEBENHAUS, Christopher Allen</creatorcontrib><creatorcontrib>MEDLEY, Jonathan William</creatorcontrib><creatorcontrib>AKTOUDIANAKIS, Evangelos</creatorcontrib><creatorcontrib>LAD, Lateshkumar Thakorlal</creatorcontrib><creatorcontrib>XU, Jie</creatorcontrib><creatorcontrib>MACHICAO TELLO, Paulo A</creatorcontrib><creatorcontrib>PHILLIPS, Barton W</creatorcontrib><creatorcontrib>SQUIRES, Neil H</creatorcontrib><creatorcontrib>YANG, Kin Shing</creatorcontrib><creatorcontrib>SIMONOVICH, Scott Preston</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GRAUPE, Michael</au><au>PARKHILL, Eric Q</au><au>WANG, Peiyuan</au><au>WATKINS, William J</au><au>NADUTHAMBI, Devan</au><au>METOBO, Samuel E</au><au>CHO, Aesop</au><au>MUKHERJEE, Prasenjit Kumar</au><au>DU, Zhimin</au><au>ZIEBENHAUS, Christopher Allen</au><au>MEDLEY, Jonathan William</au><au>AKTOUDIANAKIS, Evangelos</au><au>LAD, Lateshkumar Thakorlal</au><au>XU, Jie</au><au>MACHICAO TELLO, Paulo A</au><au>PHILLIPS, Barton W</au><au>SQUIRES, Neil H</au><au>YANG, Kin Shing</au><au>SIMONOVICH, Scott Preston</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PD-1/PD-L1 inhibitors</title><date>2023-02-16</date><risdate>2023</risdate><abstract>Abstract Compounds of Formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2021204222BB2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PD-1/PD-L1 inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T21%3A17%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GRAUPE,%20Michael&rft.date=2023-02-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2021204222BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true